Newsletter - Banner

Breadcrumb

Asset Publisher

On the genetics trail

Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...

Brain cells that aid appetite control identified

It’s rare for scientists to get what they describe as “clean” results without spending a lot of time repeating the same experiment over and over again.

Antidepressants: rise in off-label prescriptions

Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing...

New marker identified for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...

A prescription with legs!

A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...

New Cancer Stem Cell Dream Team named to attack brain cancer in children

A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Nada Jabado, hemato-oncologist at The Montreal Children's Hospital of the MUHC...

RI-MUHC leads innovative network to support children with brain-based developmental disabilities and their families

The Research Institute of the McGill University Health Centre (RI-MUHC) will lead an innovative pan-Canadian network named...

McGill Professor is the 2016 recipient of the Abraham M. Lilienfeld Award for Overall Excellence in Epidemiology

Dr. Michael S. Kramer, James McGill Professor in the Departments of Pediatrics and of Epidemiology and Biostatistics at McGill University Faculty of Medicine and Director of...

McGill University installs inaugural Chair in Pharmacoepidemiology

Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced...

Daily dose of caffeine impairs recovery after noise-induced hearing loss

A new study by investigators at the Research Institute of the McGill University Health Centre (RI-MUHC) has discovered that daily consumption of caffeine can impair recovery...

A surprise advance in the treatment of adult cancers

A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...

What is high Lipoprotein(a), and should I be concerned?

A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...

Trainees from the Research Institute of the McGill University Health Centre thrive in three-minute thesis competition

Research trainees from the Research Institute of the McGill University Health Centre took home the top three prizes recently at...

RI-MUHC team receives funding to develop improved radiation treatment devices for cancer patients

The Research Institute of the McGill University Health Centre (RI-MUHC) is proud to announce that Dr. Shirin Abbasinejad Enger, researcher from the Cancer Research Program...

New Laval clinic aims to expand reach of MUHC DOvEE project

The DOvEE project (Diagnosing Ovarian and Endometrial Cancer Early) of the McGill University Health Centre (MUHC) has opened a satellite clinic at Place des aînés de Laval.

RI-MUHC researchers discover new path to stop the spread of cancer

Investigators from the Research Institute of the McGill University Health Centre (RI-MUHC), and the Institute of Cancer Research, London (UK), have discovered...

A key to unlocking the mystery of triple negative breast cancer

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor...

A race against time to diagnose deadly weight loss in cancer patients

About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated...

New marker and potential therapy for triple negative breast cancer

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...

Dr. Morag Park awarded prestigious Robert L. Noble Prize

Dr. Morag Park, Professor of Biochemistry, Medicine and Oncology and Director of the Goodman Cancer Research Centre at McGill...